Medical Foods for Inborn Errors of Metabolism Market to Grow at a CAGR of 11.2% to reach US$ 5,768.79 Million from 2020 to 2027

    Medical Foods for Inborn Errors of Metabolism Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Amino Acid, Glytactin with GMP, Amino Acid-Modified Infant Formula with Iron, Low-Calcium/Vitamin D-Free Infant Formula with Iron, Low Protein Food, and Others); Age group (Infants, Weaning, Adolescent, and Adults); Disease (Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD), Homocystinuria, Urea Cycle Disorders, Methylmalonic Acidemia, Organic Acidurias, Propionic Acidemia, Isovaleric Acidemia, Disorders of Leucine Metabolism, Glutaric Acidemia Type I, Renal Disease, Tyrosinemia Types I and II, and Others); Forms (Powder, Liquids, Gels, and Others); Packaging (Can, Jar, Packets, Bottle, and Others); Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores, and Others); and Geography

    Publication Month: Jun 2020 | Report Code: TIPRE00011389 | No. of Pages: 243 | Category: Pharmaceuticals | Status: Published

    The medical foods for inborn errors of metabolism market was valued at US$ 2,507.80 million in 2019 and it is projected to reach US$ 5,768.79 million in 2027; it is expected to grow at a CAGR of 11.2% from 2020 to 2027.

    Medical food refers to the specialized kind of food formulated to be consumed under physician supervision and intended for specific dietary management of a particular disease or condition. These medical conditions usually have distinctive nutritional requirements based on scientific and recognized principles that are established by medical evaluation. The medical food differs from drugs; however they are intended for consumption under the medical supervision as a primary intervention. When infants are identified with inborn errors of metabolism, they are usually prescribed a special diet suitable to their particular condition that must be followed for the lifetime. The growth of the global medical foods for inborn errors of metabolism market is attributed to the increasing incidence of inborn errors of metabolism and increasing preference towards dietary food supplements. However, limitations associated to medical foods for inborn errors of metabolism is the major factor hindering the market growth.

    The global medical foods for inborn errors of metabolism market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

    Lucrative Regions for Global Medical Foods for Inborn Errors of Metabolism Market
    Lucrative Regions for Global Medical Foods for Inborn Errors of Metabolism Market

    Get more information on this report :



    Market Insights

    Growing Preference toward Dietary Supplements to Drive Global Medical Foods for Inborn Errors of Metabolism Market Growth

    The rates for consumption of nutraceutical supplements and prescribed medical food are increasing over enzyme-based therapeutic medicines. The increasing costs of healthcare and rising preference of consumers toward simple and effective remedies for disease management are likely to be responsible for the changing lineage from medicines toward medical supplements and nutritional foods. Medical food refers to a category of products that are used in dietary management of various diseases including inborn errors of metabolism that contains specific nutrients to fulfill the nutrient requirements for patients suffering from particular conditions.

    The US Food and Drug Administration (FDA) have categorized medical food under four major categories formulas for metabolic disorders, complete nutritional products, nutritionally incomplete products, and oral rehydration solutions.

    The medical foods are easy to be accessed as they do not require a prescription but are necessarily consumed under a medical supervision. In case of inborn errors of metabolism, medical foods are used as treatment options, and the products available in the market are regulated under authoritative and regulatory food and diet supplement statuses. The nutritional treatment for inborn errors of metabolism provides between 85% and 90% of nutritional requirement for a person suffering from a particular inherited disorder. Moreover, there are almost negligible side effects of these supplements, making them ideal for consumption for patients of all age groups. In recent years, the private medical insurers in the US and a few other countries are also offering reimbursement programs for the consumption of certain medical foods. Thus, the rising adoption of medical food and nutrient supplements is expected to foster the market growth over the years to come.

    Product -Based Insights

    In terms of product type, the global medical foods for inborn errors of metabolism market is segmented into amino acids, glytactin with GMP, amino acid-modified infant formula with iron, low calcium/vitamin-D infant formula with iron, low protein food and others. In 2019, the amino acid segment held largest share of the market. Also, the same segment is estimated to register the highest CAGR during the forecast period.

    Global Medical Foods for Inborn Errors of Metabolism Market, by Product– 2019 and 2027
    Global Medical Foods for Inborn Errors of Metabolism Market, by Product– 2019 and 2027

    Get more information on this report :



    Age group -Based Insights

    In terms of age group, the global medical foods for inborn errors of metabolism market is segmented into infants, weaning, adolescents and adults. In 2019, the infants segment held largest share of the market. Also, the same segment is estimated to register the highest CAGR during the forecast period.

    Disease -Based Insights

    Based on disease, the global medical foods for inborn errors of metabolism market is segmented into phenylketonuria (PKU), maple syrup urine disease (MSUD), homocystonuria, urea cycle disorders, methylmelonic academia, organic acidureas, propionic academia, isovaleric academia, disorders of leucine metabolism, glutaric academia type-1, renal disease, tyrosinemia types I and II and others. The phenylketonuria segment held the largest market share in 2019. However, the glutaric academia type-1 segment is expected to grow at the fastest rate during the coming years.

    Forms -Based Insights

    Based on forms, the global medical foods for inborn errors of metabolism market is segmented into powder, liquids, gels, and others. The powder segment held the largest market share in 2019. Also, the same segment is estimated to grow at the highest CAGR during the forecast period.

    Packaging-Based Insights

    In terms of packaging, the global medical foods for inborn errors of metabolism market is segmented into can, jar, packet, bottle, and others. The can segment held the largest share of the market in 2019. However, the packets segment is expected to grow at the highest CAGR during the forecast period.

    Distribution Channel -Based Insights

    In terms of distribution channel, the global medical foods for inborn errors of metabolism market is segmented into retail pharmacies, hospital pharmacies, online pharmacies, drug stores and others. The retail pharmacies segment held the largest share of the market in 2019. Also, the same segment is estimated to grow at the fastest rate during the forecast period.

    Strategic Insights

    The global medical foods for inborn errors of metabolism market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

    Global Medical Foods for Inborn Errors of Metabolism Market – by Product

    • Amino Acid
    • Glytactin with GMP
    • Amino Acid-Modified Infant Formula With Iron
    • Low-Calcium/Vitamin D-free Infant Formula With Iron
    • Low Protein Food
    • Others

    Global Medical Foods for Inborn Errors of Metabolism Market – by Age Group

    • Infants
    • Weaning
    • Adolescents
    • Adults

    Global Medical Foods for Inborn Errors of Metabolism Market – by Disease

    • Phenylketonuria(PKU)
    • Maple Syrup Urine Disease(MSUD)
    • Homocystinuria
    • Urea Cycle Disorders
    • Methylmalonic Acidemia
    • Organic Acidurias
    • Propionic Acidemia
    • Isovaleric aciDemia
    • Disorders of Leucine Metabolism
    • Glutaric Acidemia Type I
    • Renal Disease
    • Tyrosinemia Types I and II
    • Others

    Global Medical Foods for Inborn Errors of Metabolism Market – by Forms

    • Powder
    • Liquid
    • Gels
    • Others

    Global Medical Foods for Inborn Errors of Metabolism Market – by Packaging

    • Can
    • Jar
    • Packets
    • Bottle
    • Others

    Global Medical Foods for Inborn Errors of Metabolism Market – by Distribution Channel

    • Retail Pharmacies
    • Hospital Pharmacies
    • Online Pharmacies
    • Drugstores
    • Others

    Global Medical Foods for Inborn Errors of Metabolism Market – by Geography

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • UK
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)
      • China
      • India
      • South Korea
      • Japan
      • Australia
      • Rest of APAC
    • Middle East & Africa (MEA)
      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of MEA
    • South America and Central America (SCAM)
      • Brazil
      • Argentina
      • Rest of SCAM

    Company Profiles

    • Nestlé Health Science
    • Abbott
    • Reckitt Benckiser Group Plc
    • Ajinomoto Cambrooke, Inc.
    • Solace Nutrition
    • Primus Pharmaceuticals, Inc.
    • BioMarin Pharmaceutical
    • Danone SA
    • Galen Limited
    • PKU-MDmil

    1. Introduction

    1.1 Scope of the Study

    1.2 The Insight Partners Research Report Guidance

    1.3 Market Segmentation

    1.3.1 Medical Foods for Inborn Errors of Metabolism Market – By Product

    1.3.2 Medical Foods for Inborn Errors of Metabolism Market – By Age Group

    1.3.3 Medical Foods for Inborn Errors of Metabolism Market – By Disease

    1.3.4 Medical Foods for Inborn Errors of Metabolism Market – By Form

    1.3.5 Medical Foods for Inborn Errors of Metabolism Market – By Packaging

    1.3.6 Medical Foods for Inborn Errors of Metabolism Market – By Distribution Channel

    1.3.7 Medical Foods for Inborn Errors of Metabolism Market – By Geography

    2. Medical Foods for Inborn Errors of Metabolism Market – Key Takeaways

    3. Research Methodology

    3.1 Coverage

    3.2 Secondary Research

    3.3 Primary Research

    4. Medical Foods for Inborn Errors of Metabolism Market Landscape

    4.1 Overview

    4.2 PEST Analysis

    4.2.1 North America – PEST Analysis

    4.2.2 Europe – PEST Analysis

    4.2.3 Asia-Pacific – PEST Analysis

    4.2.4 Middle East and Africa – PEST Analysis

    4.2.5 South and Central America – PEST Analysis

    4.3 Expert Opinions

    5. Global Medical Foods for Inborn Errors of Metabolism Market – Industry Dynamics

    5.1 Market Drivers

    5.1.1 Increasing Incidences of Inborn Errors of Metabolism

    5.1.2 Growing Preference Toward Dietary Supplements

    5.2 Market Restraints

    5.2.1 Issues with Medical Foods for Inborn Errors of Metabolism

    5.3 Market Opportunities

    5.3.1 Developing Healthcare Industry Worldwide

    5.4 Future Trends

    5.4.1 Growing Online Distribution Platforms

    5.5 Impact Analysis of Drivers and Restraints

    6. Medical Foods for Inborn Errors of Metabolism Market – Global Analysis

    6.1 Global Medical Foods for Inborn Errors of Metabolism Market - Overview

    6.2 Global Medical Foods for Inborn Errors of Metabolism Market – Revenue Forecasts and Analysis

    6.3 Global Medical Foods for Inborn Errors of Metabolism Market, By Geography - Forecast And Analysis

    6.4 Market Positioning of Key Players

    7. Medical Foods for Inborn Errors of Metabolism Market Analysis– by Product

    7.1 Overview

    7.2 Medical Foods for Inborn Errors of Metabolism Market, By Product, 2019 & 2027 (%)

    7.2.1 Medical Foods for Inborn Errors of Metabolism Market Revenue and Forecasts to 2027, By Product (US$ Million)

    7.3 Amino Acid

    7.3.1 Overview

    7.3.2 Amino Acid Market Revenue and Forecasts to 2027 (US$ Million)

    7.4 Glytactin with GMP

    7.4.1 Overview

    7.4.2 Glytactin with GMP Market Revenue and Forecasts to 2027 (US$ Million)

    7.5 Amino Acid-Modified Infant Formula With Iron

    7.5.1 Overview

    7.5.2 Amino Acid-Modified Infant Formula With Iron Market Revenue and Forecasts to 2027 (US$ Million)

    7.6 Low-Calcium/Vitamin D-Free Infant Formula With Iron

    7.6.1 Overview

    7.6.2 Low-Calcium/Vitamin D-Free Infant Formula With Iron Market Revenue and Forecasts to 2027 (US$ Million)

    7.7 Low Protein Food

    7.7.1 Overview

    7.7.2 Low Protein Food Market Revenue and Forecasts to 2027 (US$ Million)

    7.8 Others

    7.8.1 Overview

    7.8.2 Others Market Revenue and Forecasts to 2027 (US$ Million)

    8. Medical Foods for Inborn Errors of Metabolism Market Analysis– by Age Group

    8.1 Overview

    8.2 Medical Foods for Inborn Errors of Metabolism Market, By Age Group, 2019 & 2027 (%)

    8.2.1 Medical Foods for Inborn Errors of Metabolism Market Revenue and Forecasts to 2027, By Age Group (US$ Million)

    8.3 Infants

    8.3.1 Overview

    8.3.2 Infants Market Revenue and Forecasts to 2027 (US$ Million)

    8.4 Weaning

    8.4.1 Overview

    8.4.2 Weaning Market Revenue and Forecasts to 2027 (US$ Million)

    8.5 Adolescent

    8.5.1 Overview

    8.5.2 Adolescent Market Revenue and Forecasts to 2027 (US$ Million)

    8.6 Adults

    8.6.1 Overview

    8.6.2 Adults Market Revenue and Forecasts to 2027 (US$ Million)

    9. Medical Foods for Inborn Errors of Metabolism Market Analysis– by Disease

    9.1 Overview

    9.2 Medical Foods for Inborn Errors of Metabolism Market, By Disease, 2019 & 2027 (% Share)

    9.2.1 Medical Foods for Inborn Errors of Metabolism Market Revenue and Forecasts to 2027, By Disease (US$ Million)

    9.3 Phenylketonuria (PKU)

    9.3.1 Overview

    9.3.2 Phenylketonuria (PKU) Market Revenue and Forecasts to 2027 (US$ Million)

    9.4 Maple Syrup Urine Disease (MSUD)

    9.4.1 Overview

    9.4.2 Maple Syrup Urine Disease (MSUD)Market Revenue and Forecasts to 2027 (US$ Million)

    9.5 Homocystinuria

    9.5.1 Overview

    9.5.2 Homocystinuria Market Revenue and Forecasts to 2027 (US$ Million)

    9.6 Urea Cycle Disorders

    9.6.1 Overview

    9.6.2 Urea Cycle Disorders Market Revenue and Forecasts to 2027 (US$ Million)

    9.7 Methylmalonic Acidemia

    9.7.1 Overview

    9.7.2 Methylmalonic Acidemia Market Revenue and Forecasts to 2027 (US$ Million)

    9.8 Organic Acidurias

    9.8.1 Overview

    9.8.2 Organic Acidurias Market Revenue and Forecasts to 2027 (US$ Million)

    9.9 Propionic Acidemia

    9.9.1 Overview

    9.9.2 Propionic Acidemia Market Revenue and Forecasts to 2027 (US$ Million)

    9.10 Isovaleric Acidemia

    9.10.1 Overview

    9.10.2 Isovaleric Acidemia Market Revenue and Forecasts to 2027 (US$ Million)

    9.11 Disorders of Leucine Metabolism

    9.11.1 Overview

    9.11.2 Disorders of Leucine Metabolism Market Revenue and Forecasts to 2027 (US$ Million)

    9.12 Glutaric Acidemia Type-I

    9.12.1 Overview

    9.12.2 Glutaric Acidemia Type-I Market Revenue and Forecasts to 2027 (US$ Million)

    9.13 Renal Disease

    9.13.1 Overview

    9.13.2 Renal Disease Market Revenue and Forecasts to 2027 (US$ Million)

    9.14 Tyrosinemia Type I and II

    9.14.1 Overview

    9.14.2 Tyrosinemia Type I and II Market Revenue and Forecasts to 2027 (US$ Million)

    9.15 Others

    9.15.1 Overview

    9.15.2 Others Market Revenue and Forecasts to 2027 (US$ Million)

    10. Medical Foods for Inborn Errors of Metabolism Market Analysis– by Form

    10.1 Overview

    10.2 Medical Foods for Inborn Errors of Metabolism Market, By Form, 2019 & 2027 (% Share)

    10.2.1 Medical Foods for Inborn Errors of Metabolism Market Revenue and Forecasts to 2027, By Form (US$ Million)

    10.3 Powder

    10.3.1 Overview

    10.3.2 Powder Market Revenue and Forecasts to 2027 (US$ Million)

    10.4 Liquids

    10.4.1 Overview

    10.4.2 Liquids Market Revenue and Forecasts to 2027 (US$ Million)

    10.5 Gels

    10.5.1 Overview

    10.5.2 Gels Market Revenue and Forecasts to 2027 (US$ Million)

    10.6 Others

    10.6.1 Overview

    10.6.2 Others Market Revenue and Forecasts to 2027 (US$ Million)

    11. Medical Foods for Inborn Errors of Metabolism Market Analysis– by Packaging

    11.1 Overview

    11.2 Medical Foods for Inborn Errors of Metabolism Market, By Packaging, 2019 & 2027 (% Share)

    11.2.1 Medical Foods for Inborn Errors of Metabolism Market Revenue and Forecasts to 2027, By Packaging (US$ Million)

    11.3 Can

    11.3.1 Overview

    11.3.2 Can Market Revenue and Forecasts to 2027 (US$ Million)

    11.4 Jar

    11.4.1 Overview

    11.4.2 Jar Market Revenue and Forecasts to 2027 (US$ Million)

    11.5 Packet

    11.5.1 Overview

    11.5.2 Packet Market Revenue and Forecasts to 2027 (US$ Million)

    11.6 Bottle

    11.6.1 Overview

    11.6.2 Bottle Market Revenue and Forecasts to 2027 (US$ Million)

    11.7 Others

    11.7.1 Overview

    11.7.2 Others Market Revenue and Forecasts to 2027 (US$ Million)

    12. Medical Foods for Inborn Errors of Metabolism Market Analysis– by Distribution Channel

    12.1 Overview

    12.2 Medical Foods for Inborn Errors of Metabolism Market, By Distribution Channel, 2019 & 2027 (% Share)

    12.2.1 Medical Foods for Inborn Errors of Metabolism Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Million)

    12.3 Retail Pharmacies

    12.3.1 Overview

    12.3.2 Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Million)

    12.4 Hospital Pharmacies

    12.4.1 Overview

    12.4.2 Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Million)

    12.5 Online Pharmacies

    12.5.1 Overview

    12.5.2 Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Million)

    12.6 Drugstores

    12.6.1 Overview

    12.6.2 Drugstores Market Revenue and Forecasts to 2027 (US$ Million)

    12.7 Others

    12.7.1 Overview

    12.7.2 Others Market Revenue and Forecasts to 2027 (US$ Million)

    13. Medical Foods for Inborn Errors of Metabolism Market – Geographic Analysis

    13.1 North America: Medical Foods for Inborn Errors of Metabolism Market

    13.1.1 Overview

    13.1.2 North America: Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.1.3 North America: Medical Foods for Inborn Errors of Metabolism Market, by Product – Revenue and Forecast to 2027 (USD Million)

    13.1.4 North America: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

    13.1.5 North America: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    13.1.6 North America: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

    13.1.7 North America: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

    13.1.8 North America: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

    13.1.9 North America: Medical Foods for Inborn Errors of Metabolism Market, by Country, 2019 & 2027 (%)

    13.1.10 US: Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.1.10.1 US: Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.1.10.1.1 US: Medical Foods for Inborn Errors of Metabolism Market, by Product – Revenue and Forecast to 2027 (USD Million)

    13.1.10.1.2 US: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

    13.1.10.1.3 US: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    13.1.10.1.4 US: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

    13.1.10.1.5 US: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

    13.1.10.1.6 US: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

    13.1.11 Canada: Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.1.11.1 Canada: Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.1.11.1.1 Canada: Medical Foods for Inborn Errors of Metabolism Market, by Product – Revenue and Forecast to 2027 (USD Million)

    13.1.11.1.2 Canada: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

    13.1.11.1.3 Canada: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    13.1.11.1.4 Canada: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

    13.1.11.1.5 Canada: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

    13.1.11.1.6 Canada: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

    13.1.12 Mexico:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.1.12.1 Mexico:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.1.12.1.1 Mexico:Medical Foods for Inborn Errors of Metabolism Market, by Product – Revenue and Forecast to 2027 (USD Million)

    13.1.12.1.2 Mexico:Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

    13.1.12.1.3 Mexico: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    13.1.12.1.4 Mexico:Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

    13.1.12.1.5 Mexico:Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

    13.1.12.1.6 Mexico:Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

    13.2 Europe: Medical Foods For Inborn Errors Of Metabolism Market

    13.2.1 Overview

    13.2.2 Europe: Medical Foods For Inborn Errors Of Metabolism Market - Revenue and Forecast to 2027 (USD Million)

    13.2.3 Europe: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

    13.2.4 Europe: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027 (USD Million)

    13.2.5 Europe: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027 (USD Million)

    13.2.6 Europe: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

    13.2.7 Europe: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

    13.2.8 Europe: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027 (USD Million)

    13.2.9 Europe: Medical Foods For Inborn Errors Of Metabolism Market, by Country, 2019 & 2027 (%)

    13.2.10 Germany: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.2.10.1 Germany: Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.2.10.1.1 Germany: Medical Foods for Inborn Errors of Metabolism Market, by Product, 2018–2027 (USD Million)

    13.2.10.1.2 Germany: Medical Foods for Inborn Errors of Metabolism, Market, by Age Group, 2018–2027 (USD Million)

    13.2.10.1.3 Germany: Medical Foods for Inborn Errors of Metabolism, Market, by Disease, 2018–2027 (USD Million)

    13.2.10.1.4 Germany: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

    13.2.10.1.5 Germany: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

    13.2.10.1.6 Germany: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027 (USD Million)

    13.2.11 UK: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.2.11.1 UK: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.2.11.1.1 UK: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

    13.2.11.1.2 UK: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027 (USD Million)

    13.2.11.1.3 UK: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027 (USD Million)

    13.2.11.1.4 UK: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

    13.2.11.1.5 UK: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

    13.2.11.1.6 UK: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027 (USD Million)

    13.2.12 France: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.2.12.1 France: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.2.12.1.1 France: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

    13.2.12.1.2 France: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027 (USD Million)

    13.2.12.1.3 France: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027 (USD Million)

    13.2.12.1.4 France: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

    13.2.12.1.5 France: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

    13.2.12.1.6 France: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027 (USD Million)

    13.2.13 Spain: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.2.13.1 Spain: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.2.13.1.1 Spain: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

    13.2.13.1.2 Spain: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027 (USD Million)

    13.2.13.1.3 Spain: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027 (USD Million)

    13.2.13.1.4 Spain: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

    13.2.13.1.5 Spain: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

    13.2.13.1.6 Spain: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027 (USD Million)

    13.2.14 Italy: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.2.14.1 Italy: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.2.14.1.1 Italy: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

    13.2.14.1.2 Italy: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027 (USD Million)

    13.2.14.1.3 Italy: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027 (USD Million)

    13.2.14.1.4 Italy: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

    13.2.14.1.5 Italy: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

    13.2.14.1.6 Italy: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027 (USD Million)

    13.3 Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market

    13.3.1 Overview

    13.3.2 Asia Pacific:Medical Foods for Inborn Errors of Metabolism Market- Revenue and Forecast to 2027 (USD Million)

    13.3.3 Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market, by Product – Revenue and Forecast to 2027 (USD Million)

    13.3.4 Asia Pacific:Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

    13.3.5 Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    13.3.6 Asia Pacific:Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

    13.3.7 Asia Pacific:Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

    13.3.8 Asia Pacific:Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

    13.3.9 Asia Pacific:Medical Foods for Inborn Errors of Metabolism Market, by Country, 2019 & 2027 (%)

    13.3.10 China:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.3.10.1 China:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.3.10.1.1 China:Medical Foods for Inborn Errors of Metabolism Market, by Product – Revenue and Forecast to 2027 (USD Million)

    13.3.10.1.2 China:Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

    13.3.10.1.3 China: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    13.3.10.1.4 China:Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

    13.3.10.1.5 China:Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

    13.3.10.1.6 China:Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

    13.3.11 Japan:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.3.11.1 Japan:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.3.11.1.1 Japan:Medical Foods for Inborn Errors of Metabolism Market, by Product – Revenue and Forecast to 2027 (USD Million)

    13.3.11.1.2 Japan:Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

    13.3.11.1.3 Japan: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    13.3.11.1.4 Japan:Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

    13.3.11.1.5 Japan:Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

    13.3.11.1.6 Japan:Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

    13.3.12 India:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.3.12.1 India:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.3.12.1.1 India:Medical Foods for Inborn Errors of Metabolism Market, by Product – Revenue and Forecast to 2027 (USD Million)

    13.3.12.1.2 India:Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

    13.3.12.1.3 India: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    13.3.12.1.4 India:Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

    13.3.12.1.5 India:Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

    13.3.12.1.6 India:Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

    13.3.13 South Korea:Medical Foods for Inborn Errors of Metabolism Market– Revenue and Forecast to 2027 (USD Million)

    13.3.13.1 South Korea:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.3.13.1.1 South Korea:Medical Foods for Inborn Errors of Metabolism Market, by Product – Revenue and Forecast to 2027 (USD Million)

    13.3.13.1.2 South Korea:Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

    13.3.13.1.3 South Korea: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    13.3.13.1.4 South Korea:Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

    13.3.13.1.5 South Korea:Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

    13.3.13.1.6 South Korea:Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

    13.3.14 Australia:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.3.14.1 Australia:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.3.14.1.1 Australia:Medical Foods for Inborn Errors of Metabolism Market, by Product – Revenue and Forecast to 2027 (USD Million)

    13.3.14.1.2 Australia:Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

    13.3.14.1.3 Australia: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    13.3.14.1.4 Australia: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

    13.3.14.1.5 Australia:Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

    13.3.14.1.6 Australia:Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

    13.4 Middle East and Africa: Medical Foods For Inborn Errors Of Metabolism Market

    13.4.1 Overview

    13.4.2 Middle East and Africa: Medical Foods For Inborn Errors Of Metabolism Market- Revenue and Forecast to 2027 (USD Million)

    13.4.3 Middle East and Africa: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

    13.4.4 Middle East and Africa: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027 (USD Million)

    13.4.5 Middle East and Africa: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027 (USD Million)

    13.4.6 Middle East and Africa: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

    13.4.7 Middle East and Africa: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

    13.4.8 Middle East and Africa: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027 (USD Million)

    13.4.9 Middle East and Africa: Medical Foods For Inborn Errors Of Metabolism Market, by Country, 2019 & 2027 (%)

    13.4.10 Saudi Arabia: Medical Foods For Inborn Errors Of Metabolism Market– Revenue and Forecast to 2027 (USD Million)

    13.4.10.1 Saudi Arabia: Medical Foods For Inborn Errors Of Metabolism Market– Revenue and Forecast to 2027 (USD Million)

    13.4.10.1.1 Saudi Arabia: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

    13.4.10.1.2 Saudi Arabia: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027 (USD Million)

    13.4.10.1.3 Saudi Arabia: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027 (USD Million)

    13.4.10.1.4 Saudi Arabia: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

    13.4.10.1.5 Saudi Arabia: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

    13.4.10.1.6 Saudi Arabia: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027 (USD Million)

    13.4.11 UAE: Medical Foods For Inborn Errors Of Metabolism Market– Revenue and Forecast to 2027 (USD Million)

    13.4.11.1 UAE: Medical Foods For Inborn Errors Of Metabolism Market– Revenue and Forecast to 2027 (USD Million)

    13.4.11.1.1 UAE: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

    13.4.11.1.2 UAE: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027 (USD Million)

    13.4.11.1.3 UAE: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027 (USD Million)

    13.4.11.1.4 UAE: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

    13.4.11.1.5 UAE: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

    13.4.11.1.6 UAE: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027 (USD Million)

    13.4.12 South Africa: Medical Foods For Inborn Errors Of Metabolism Market– Revenue and Forecast to 2027 (USD Million)

    13.4.12.1 South Africa: Medical Foods For Inborn Errors Of Metabolism Market– Revenue and Forecast to 2027 (USD Million)

    13.4.12.1.1 South Africa: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

    13.4.12.1.2 South Africa: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027 (USD Million)

    13.4.12.1.3 South Africa: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027 (USD Million)

    13.4.12.1.4 South Africa: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

    13.4.12.1.5 South Africa: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

    13.4.12.1.6 South Africa: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027 (USD Million)

    13.5 South and Central America: Medical Foods For Inborn Errors Of Metabolism Market

    13.5.1 Overview

    13.5.2 South and Central America: Medical Foods For Inborn Errors Of Metabolism Market - Revenue and Forecast to 2027 (US$ Million)

    13.5.3 South and Central America: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

    13.5.4 South and Central America: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027 (USD Million)

    13.5.5 South and Central America: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027 (USD Million)

    13.5.6 South and Central America: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

    13.5.7 South and Central America: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

    13.5.8 South and Central America: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027 (USD Million)

    13.5.9 South and Central America: Medical Foods For Inborn Errors Of Metabolism Market, by Country, 2019 & 2027 (%)

    13.5.10 Brazil: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.5.10.1 Brazil: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.5.10.1.1 Brazil: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

    13.5.10.1.2 Brazil: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027 (USD Million)

    13.5.10.1.3 Brazil: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027 (USD Million)

    13.5.10.1.4 Brazil: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

    13.5.10.1.5 Brazil: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

    13.5.10.1.6 Brazil: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027 (USD Million)

    13.5.11 Argentina: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.5.11.1 Argentina: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    13.5.11.1.1 Argentina: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

    13.5.11.1.2 Argentina: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027 (USD Million)

    13.5.11.1.3 Argentina: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027 (USD Million)

    13.5.11.1.4 Argentina: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

    13.5.11.1.5 Argentina: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

    13.5.11.1.6 Argentina: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027 (USD Million)

    14. Impact of COVID-19 Pandemic on Global Medical Foods for Inborn Errors of Metabolism Market

    14.1 North America: Impact Assessment of COVID-19 Pandemic

    14.2 Europe: Impact Assessment Of COVID-19 Pandemic

    14.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

    14.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

    15. Medical Foods For Inborn Errors Of Metabolism Market – Industry Landscape

    15.1 Overview

    15.2 Growth Strategies Done by the Companies in the Market, (%)

    15.3 Organic Developments

    15.3.1 Overview

    15.4 Inorganic Developments

    15.4.1 Overview

    16. Company Profiles

    16.1 Nestlé

    16.1.1 Key Facts

    16.1.2 Business Description

    16.1.3 Products and Services

    16.1.4 Financial Overview

    16.1.5 SWOT Analysis

    16.1.6 Key Developments

    16.2 Abbott

    16.2.1 Key Facts

    16.2.2 Business Description

    16.2.3 Products and Services

    16.2.4 Financial Overview

    16.2.5 SWOT Analysis

    16.2.6 Key Developments

    16.3 Reckitt Benckiser Group Plc

    16.3.1 Key Facts

    16.3.2 Business Description

    16.3.3 Products and Services

    16.3.4 Financial Overview

    16.3.5 SWOT Analysis

    16.3.6 Key Developments

    16.4 Ajinomoto Co. Inc.

    16.4.1 Key Facts

    16.4.2 Business Description

    16.4.3 Products and Services

    16.4.4 Financial Overview

    16.4.5 SWOT Analysis

    16.4.6 Key Developments

    16.5 Solace Nutrition

    16.5.1 Key Facts

    16.5.2 Business Description

    16.5.3 Products and Services

    16.5.4 Financial Overview

    16.5.5 SWOT Analysis

    16.5.6 Key Developments

    16.6 Primus Pharmaceuticals, Inc.

    16.6.1 Key Facts

    16.6.2 Business Description

    16.6.3 Products and Services

    16.6.4 Financial Overview

    16.6.5 SWOT Analysis

    16.6.6 Key Developments

    16.7 BioMarin Pharmaceutical Inc.

    16.7.1 Key Facts

    16.7.2 Business Description

    16.7.3 Products and Services

    16.7.4 Financial Overview

    16.7.5 SWOT Analysis

    16.7.6 Key Developments

    16.8 Danone SA

    16.8.1 Key Facts

    16.8.2 Business Description

    16.8.3 Products and Services

    16.8.4 Financial Overview

    16.8.5 SWOT Analysis

    16.8.6 Key Developments

    16.9 Galen Limited

    16.9.1 Key Facts

    16.9.2 Business Description

    16.9.3 Products and Services

    16.9.4 Financial Overview

    16.9.5 SWOT Analysis

    16.9.6 Key Developments

    16.10 PKU-MDMIL

    16.10.1 Key Facts

    16.10.2 Business Description

    16.10.3 Products and Services

    16.10.4 Financial Overview

    16.10.5 SWOT Analysis

    16.10.6 Key Developments

    17. Appendix

    17.1 About The Insight Partners

    17.2 Glossary of Terms

    LIST OF TABLES

    Table 1. Medical Foods for Inborn Errors of Metabolism Market Revenue And Forecasts to 2027, By Product (US$ Million)

    Table 2. Medical Foods for Inborn Errors of Metabolism Market Revenue and Forecasts to 2027, By Age Group (US$ Million)

    Table 3. Medical Foods for Inborn Errors of Metabolism Market Revenue And Forecasts to 2027, By Disease (US$ Million)

    Table 4. Medical Foods for Inborn Errors of Metabolism Market Revenue And Forecasts to 2027, By Form(US$ Million)

    Table 5. Medical Foods for Inborn Errors of Metabolism Market Revenue And Forecasts to 2027, By Packaging (US$ Million)

    Table 6. Medical Foods for Inborn Errors of Metabolism Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Million)

    Table 7. North America: Medical Foods for Inborn Errors of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 8. North America: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

    Table 9. North America: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 10. North America: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

    Table 11. North America: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

    Table 12. North America: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

    Table 13. US: Medical Foods for Inborn Errors of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 14. US: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

    Table 15. US: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 16. US: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

    Table 17. US: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

    Table 18. US: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

    Table 19. Canada: Medical Foods for Inborn Errors of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 20. Canada: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

    Table 21. Canada: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 22. Canada: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

    Table 23. Canada: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

    Table 24. Canada: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

    Table 25. Mexico: Medical Foods for Inborn Errors of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 26. Mexico: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

    Table 27. Mexico: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 28. Mexico: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

    Table 29. Mexico: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

    Table 30. Mexico: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

    Table 31. Europe Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 32. Europe Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

    Table 33. Europe Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 34. Europe Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027 (USD Million)

    Table 35. Europe Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

    Table 36. Europe Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 37. Germany Medical Foods for Inborn Errors of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 38. Germany Medical Foods for Inborn Errors of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

    Table 39. Germany Medical Foods for Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 40. Germany Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027 (USD Million)

    Table 41. Germany Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

    Table 42. Germany Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 43. UK Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 44. UK Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

    Table 45. UK Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 46. UK Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027 (USD Million)

    Table 47. UK Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

    Table 48. UK Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 49. France Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 50. France Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

    Table 51. France Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 52. France Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027 (USD Million)

    Table 53. France Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

    Table 54. France Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 55. Spain Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 56. Spain Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

    Table 57. Spain Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 58. Spain Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027 (USD Million)

    Table 59. Spain Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

    Table 60. Spain Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 61. Italy Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 62. Italy Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

    Table 63. Italy Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 64. Italy Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027 (USD Million)

    Table 65. Italy Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

    Table 66. Italy Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 67. Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 68. Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

    Table 69. Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 70. Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

    Table 71. Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

    Table 72. Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

    Table 73. China: Medical Foods for Inborn Errors of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 74. China: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

    Table 75. China: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 76. China: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

    Table 77. China: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

    Table 78. China: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

    Table 79. Japan: Medical Foods for Inborn Errors of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 80. Japan: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

    Table 81. Japan: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 82. Japan: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

    Table 83. Japan: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

    Table 84. Japan: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

    Table 85. India: Medical Foods for Inborn Errors of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 86. India: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

    Table 87. India: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 88. India: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

    Table 89. India: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

    Table 90. India: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

    Table 91. South Korea: Medical Foods for Inborn Errors of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 92. South Korea: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

    Table 93. South Korea: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 94. South Korea: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

    Table 95. South Korea: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

    Table 96. South Korea: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

    Table 97. Australia: Medical Foods for Inborn Errors of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 98. Australia: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

    Table 99. Australia: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 100. Australia: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

    Table 101. Australia: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

    Table 102. Australia: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

    Table 103. Middle East and Africa Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 104. Middle East and Africa Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

    Table 105. Middle East and Africa Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 106. Middle East and Africa Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027 (USD Million)

    Table 107. Middle East and Africa Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

    Table 108. Middle East and Africa Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 109. Saudi Arabia Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 110. Saudi Arabia Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

    Table 111. Saudi Arabia Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 112. Saudi Arabia Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027 (USD Million)

    Table 113. Saudi Arabia Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

    Table 114. Saudi Arabia Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 115. UAE Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 116. UAE Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

    Table 117. UAE Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 118. UAE Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027 (USD Million)

    Table 119. UAE Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

    Table 120. UAE Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 121. South Africa Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 122. South Africa Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

    Table 123. South Africa Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 124. South Africa Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027 (USD Million)

    Table 125. South Africa Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

    Table 126. South Africa Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 127. South and Central America Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 128. South and Central America Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

    Table 129. South and Central America Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 130. South and Central America Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027 (USD Million)

    Table 131. South and Central America Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

    Table 132. South and Central America Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 133. Brazil Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 134. Brazil Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

    Table 135. Brazil Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 136. Brazil Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027 (USD Million)

    Table 137. Brazil Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

    Table 138. Brazil Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 139. Argentina Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

    Table 140. Argentina Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

    Table 141. Argentina Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

    Table 142. Argentina Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027 (USD Million)

    Table 143. Argentina Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

    Table 144. Argentina Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

    Table 145. Organic Developments Done By Companies

    Table 146. Inorganic Developments Done By Companies

    Table 147. Glossary of Terms, Medical Foods for Inborn Errors of Metabolism Market

    LIST OF FIGURES

    Figure 1. Medical Foods for Inborn Errors of Metabolism Market Segmentation

    Figure 2. Medical Foods for Inborn Errors of Metabolism Market – By Geography

    Figure 3. Global Medical Foods for Inborn Errors of Metabolism Market Overview

    Figure 4. Amino Acid Segment Held Largest Share of Product Segment In Medical Foods for Inborn Errors of Metabolism Market

    Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

    Figure 6. Global Medical Foods for Inborn Errors of Metabolism Market, By Geography (US$ Million)

    Figure 7. Global Medical Foods for Inborn Errors of Metabolism Market- Leading Country Markets (US$ Million)

    Figure 8. Global Medical Foods for Inborn Errors of Metabolism Market, Industry Landscape

    Figure 9. North America PEST Analysis

    Figure 10. Europe PEST Analysis

    Figure 11. Asia-Pacific PEST Analysis

    Figure 12. Middle East and Africa PEST Analysis

    Figure 13. South and Central America PEST Analysis

    Figure 14. Medical Foods for Inborn Errors of Metabolism Market Impact Analysis of Drivers and Restraints

    Figure 15. Global Medical Foods for Inborn Errors of Metabolism Market – Revenue Forecasts and Analysis – 2018- 2027

    Figure 16. Global Medical Foods for Inborn Errors of Metabolism Market– By Geography Forecast and Analysis – 2019- 2027

    Figure 17. Market Positioning Of Key Players In Global Medical Foods for Inborn Errors of Metabolism Market

    Figure 18. Medical Foods for Inborn Errors of Metabolism Market, by Product, 2019 & 2027 (%)

    Figure 19. Amino Acid Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 20. Glytactin with GMP Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 21. Amino Acid-Modified Infant Formula With Iron Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 22. Low-Calcium/Vitamin D-Free Infant Formula With Iron Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 23. Low Protein Food Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 24. Others Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 25. Medical Foods for Inborn Errors of Metabolism Market, by Age Group, 2019 & 2027 (%)

    Figure 26. Infants Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 27. Weaning Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 28. Adolescent Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 29. Adults Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 30. Medical Foods for Inborn Errors of Metabolism Market, by Disease, 2019 & 2027 (% Share)

    Figure 31. Phenylketonuria (PKU) Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 32. Maple Syrup Urine Disease(MSUD) Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 33. Homocystinuria Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 34. Urea Cycle Disorders Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 35. Methylmalonic Acidemia Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 36. Organic Acidurias Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 37. Propionic Acidemia Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 38. Isovaleric Acidemia Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 39. Disorders of Leucine Metabolism Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 40. Glutaric Acidemia Type-I Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 41. Renal Disease Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 42. Tyrosinemia Type I and II Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 43. Others Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 44. Medical Foods for Inborn Errors of Metabolism Market, by Form, 2019 & 2027 (% Share)

    Figure 45. Powder Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 46. Liquids Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 47. Gels Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 48. Others Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 49. Medical Foods for Inborn Errors of Metabolism Market, by Packaging, 2019 & 2027 (% Share)

    Figure 50. Can Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 51. Jar Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 52. Packet Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 53. Bottle Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 54. Others Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 55. Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel, 2019 & 2027 (% Share)

    Figure 56. Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 57. Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 58. Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 59. Drugstores Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 60. Others Market Revenue and Forecasts to 2027 (US$ Million)

    Figure 61. North America: Medical Foods for Inborn Errors of Metabolism Market, by Key Country – Revenue (2019) (USD Million)

    Figure 62. North America: Medical Foods for Inborn Errors of Metabolism Market Revenue and Forecast to 2027 (USD Million)

    Figure 63. North America: Medical Foods for Inborn Errors of Metabolism Market, by Country, 2019 & 2027 (%)

    Figure 64. US: Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    Figure 65. Canada: Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    Figure 66. Mexico:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    Figure 67. Europe: Medical Foods For Inborn Errors Of Metabolism Market, by Key Country – Revenue (2019) (USD Million)

    Figure 68. Europe Medical Foods For Inborn Errors Of Metabolism Market Revenue and Forecast to 2027 (USD Million)

    Figure 69. Europe: Medical Foods For Inborn Errors Of Metabolism Market, by Country, 2019 & 2027 (%)

    Figure 70. Germany: Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    Figure 71. UK: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    Figure 72. France: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    Figure 73. Spain: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    Figure 74. Italy: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    Figure 75. Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market, by Key Country – Revenue (2019) (USD Million)

    Figure 76. Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market Revenue and Forecast to 2027 (USD Million)

    Figure 77. Asia Pacific:Medical Foods for Inborn Errors of Metabolism Market, by Country, 2019 & 2027 (%)

    Figure 78. China:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    Figure 79. Japan:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    Figure 80. India:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    Figure 81. South Korea:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    Figure 82. Australia:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    Figure 83. Middle East and Africa: Medical Foods For Inborn Errors Of Metabolism Market, by Key Country – Revenue (2019) (USD Million)

    Figure 84. Middle East and Africa Medical Foods For Inborn Errors Of Metabolism Market Revenue and Forecast to 2027 (USD Million)

    Figure 85. Middle East and Africa: Medical Foods For Inborn Errors Of Metabolism Market, by Country, 2019 & 2027 (%)

    Figure 86. Saudi Arabia: Medical Foods For Inborn Errors Of Metabolism Market– Revenue and Forecast to 2027 (USD Million)

    Figure 87. UAE: Medical Foods For Inborn Errors Of Metabolism Market– Revenue and Forecast to 2027 (USD Million)

    Figure 88. South Africa: Medical Foods For Inborn Errors Of Metabolism Market– Revenue and Forecast to 2027 (USD Million)

    Figure 89. South and Central America: Medical Foods For Inborn Errors Of Metabolism Market, by Key Country – Revenue (2019) (USD Million)

    Figure 90. South and Central America Medical Foods For Inborn Errors Of Metabolism Market Revenue and Forecast to 2027 (USD Million)

    Figure 91. South and Central America: Medical Foods For Inborn Errors Of Metabolism Market, by Country, 2019 & 2027 (%)

    Figure 92. Brazil: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    Figure 93. Argentina: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

    Figure 94. Impact of COVID-19 Pandemic in North American Country Markets

    Figure 95. Impact of COVID-19 Pandemic in European Country Markets

    Figure 96. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets

    Figure 97. Impact Of COVID-19 Pandemic in Rest of the World Countries Market

    Figure 98. Growth Strategies Done by the Companies in the Market, (%)

    The List of Companies - Medical Foods for Inborn Errors of Metabolism Market 

    1. Nestlé Health Science
    2. Nutricia
    3. Solace Nutrition
    4. Abbott
    5. Mead Johnson and Company, LLC.
    6. BioMarin Pharmaceutical
    7. Ajinomoto Cambrooke, Inc.
    8. Poa Pharma
    9. PKU-MDmil
    10. Primus Pharmaceuticals, Inc.
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the medical foods for inborn errors of metabolism market.
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in the global medical foods for inborn errors of metabolism market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
    TIPRE00011389
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market



    Frequently Asked Questions

    Medical food refers to the specialized kind of food formulated to be consumed under physician supervision and intended for specific dietary management of a particular disease or condition. These medical conditions usually have distinctive nutritional requirements based on scientific and recognized principles that are established by medical evaluation. The medical food differs from drugs; however they are intended for consumption under the medical supervision as a primary intervention. When infants are identified with inborn errors of metabolism, they are usually prescribed a special diet suitable to their particular condition that must be followed for the lifetime.
    Factors such as increasing incidence of inborn errors of metabolism and increasing preference towards dietary food supplements are expected to boost the growth of the global medical foods for inborn errors of metabolism market. However, the market is likely to get impacted by the limitations associated to medical foods for inborn errors of metabolism during the forecast period.
    North America is the largest market for the medical foods for inborn errors of metabolism market. The factors that are responsible for the dominance of the region include rising government support well-developed healthcare facilities, presence of top market players, increasing number of patients with inborn errors of metabolism and rising awareness regarding benefits of consuming nutritional supplements under medical supervision. Similarly, in Canada, increasing government initiatives to raise awareness regarding rare genetic disorders and well-established healthcare infrastructure are leading to market growth. Asia-Pacific is anticipated to register as the fastest-growing region in the global medical foods for inborn errors of metabolism market. The growth of the market is expected to be fastest in countries such as China, India, and Japan. The factors that are expected to drive the market growth include large number of patients suffering with genetic diseases and increasing launch of innovative products by local players in the Asian countries. Increasing collaborations and partnerships are also responsible for the growth of the market in the Asian region.

    Pricing
    • $3000
    • $4550 $3640
    • $6550 $5240
    • $8550 $6840

        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount   Speak to Analyst